U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C36H39N3O6
Molecular Weight 609.7114
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIGULDIPINE

SMILES

COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5

InChI

InChIKey=SVJMLYUFVDMUHP-XIFFEERXSA-N
InChI=1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m0/s1

HIDE SMILES / InChI

Molecular Formula C36H39N3O6
Molecular Weight 609.7114
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

S-(+)-niguldipine is a more active enantiomer and is a selective antagonist for the and α1A-adrenoceptor. In addition, it can be used for discriminating of alpha 1A- from alpha 1B-adrenoceptors. There were made attempts to investigate the antidepressant action of S-(+)-niguldipine on rats, but that studies were unsuccessful.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
52.0 pM [Ki]
78.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors.
1989 May 11
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
1994 Apr
The involvement of alpha2-adrenoceptors in the anticonvulsive effect of swim stress in mice.
2001 Oct
Patents

Patents

Sample Use Guides

in rats: Drug was administered at three time points (24, 5, and 1 h before testing), and the effects of three doses (2, 5, and 10 mg/kg) was investigated. S-(+)-Niguldipine produced no antidepressant-like effects other than a 14% reduction in immobility time at the highest dose.
Route of Administration: Oral
In Vitro Use Guide
(+)-Niguldipine (Ki: 78 nmol/l) and (-)-niguldipine (Ki: 58 nmol/l) bound with approximately equal affinity to the alpha 1-adrenoceptors ('alpha 1B') in liver cell membranes. The (+)-niguldipine alpha 1-adrenoceptor inhibition data for rat brain cortex membranes were better fitted by a two-site model. The high-affinity component ('alpha 1A') had a Ki value of 52 pmol/l in competition experiments with [3H]prazosin. The low-affinity site (alpha 1B) had 200- to 600-fold less affinity. (+)-Niguldipine was the most selective compound for discriminating alpha 1A- from alpha 1B-adrenoceptors and is a novel prototype for 1,4-DHPs which bind with nearly equal affinity to skeletal muscle and brain or heart 1,4-DHP receptors.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:39:30 GMT 2023
Edited
by admin
on Fri Dec 15 15:39:30 GMT 2023
Record UNII
Z81N45O25Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NIGULDIPINE
INN   WHO-DD  
INN  
Official Name English
Niguldipine [WHO-DD]
Common Name English
(-)-(S)-3-(4,4-DIPHENYLPIPERIDINO)PROPYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(M-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE
Systematic Name English
niguldipine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C333
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
Code System Code Type Description
INN
6106
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
CAS
113165-32-5
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
DRUG BANK
DB09239
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
WIKIPEDIA
NIGULDIPINE
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
SMS_ID
100000083880
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
PUBCHEM
60602
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
FDA UNII
Z81N45O25Z
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
MESH
C054074
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
EPA CompTox
DTXSID60274008
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL405355
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
NCI_THESAURUS
C84018
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
EVMPD
SUB09284MIG
Created by admin on Fri Dec 15 15:39:30 GMT 2023 , Edited by admin on Fri Dec 15 15:39:30 GMT 2023
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER
Related Record Type Details
ACTIVE MOIETY